Skip to content
10-Q

Quarterly Report

REGENERX BIOPHARMACEUTICALS, INC.

0001410578-22-003350

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 8, 2022 143.55M sh
Shares Diluted Q3 2022 · Sep 30, 2022 143.55M sh
Shares Diluted Q3 2022 · Sep 30, 2022 143.55M sh
Shares Diluted Q3 2022 · Sep 30, 2021 143.48M sh
Shares Diluted Q3 2022 · Sep 30, 2021 136.92M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$753.2K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$698.51K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $478.41K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $1.23M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$3.14M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$2.86M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$2.57M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$2.23M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$1.87M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$1.55M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$3.12M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$2.82M
Current Liabilities Q3 2022 · Sep 30, 2022 $476.22K
Current Liabilities Q3 2022 · Dec 31, 2021 $429.93K
Total Liabilities Q3 2022 · Sep 30, 2022 $3.72M
Total Liabilities Q3 2022 · Dec 31, 2021 $3.51M
Current Assets Q3 2022 · Sep 30, 2022 $499.41K
Current Assets Q3 2022 · Dec 31, 2021 $1.25M
Total Assets Q3 2022 · Sep 30, 2022 $580.99K
Total Assets Q3 2022 · Dec 31, 2021 $1.28M
Eps Diluted Q3 2022 · Sep 30, 2022 $0.00
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.01
Eps Diluted Q3 2022 · Sep 30, 2021 $0.00
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.01
Eps Basic Q3 2022 · Sep 30, 2022 $0.00
Eps Basic Q3 2022 · Sep 30, 2022 −$0.01
Eps Basic Q3 2022 · Sep 30, 2021 $0.00
Eps Basic Q3 2022 · Sep 30, 2021 −$0.01
Sga Expense Q3 2022 · Sep 30, 2022 $303.65K
Sga Expense Q3 2022 · Sep 30, 2022 $1.15M
Sga Expense Q3 2022 · Sep 30, 2021 $417.57K
Sga Expense Q3 2022 · Sep 30, 2021 $1.01M
Rd Expense Q3 2022 · Sep 30, 2022 $0
Rd Expense Q3 2022 · Sep 30, 2022 $0
Rd Expense Q3 2022 · Sep 30, 2021 $5.66K
Rd Expense Q3 2022 · Sep 30, 2021 $6.64K
Net Income Q3 2022 · Sep 30, 2022 −$366.51K
Net Income Q3 2022 · Sep 30, 2022 −$1.34M
Net Income Q3 2022 · Jun 30, 2022 −$545.98K
Net Income Q3 2022 · Mar 31, 2022 −$424.07K
Net Income Q3 2022 · Sep 30, 2021 −$429.85K
Net Income Q3 2022 · Sep 30, 2021 −$1.15M
Net Income Q3 2022 · Jun 30, 2021 −$338.63K
Net Income Q3 2022 · Mar 31, 2021 −$379.69K
Operating Income Q3 2022 · Sep 30, 2022 −$284.46K
Operating Income Q3 2022 · Sep 30, 2022 −$1.09M
Operating Income Q3 2022 · Sep 30, 2021 −$404.05K
Operating Income Q3 2022 · Sep 30, 2021 −$960.91K
Revenue Q3 2022 · Sep 30, 2022 $19.19K
Revenue Q3 2022 · Sep 30, 2022 $57.57K
Revenue Q3 2022 · Sep 30, 2021 $19.19K
Revenue Q3 2022 · Sep 30, 2021 $57.57K